Bought this stock at $2.55 was looking to sell it Monday to buy more chln but found that it may be on the edge of "success or crater on failure"
Still listed as a "strong buy"
<font> http://www.tradingmarkets.com/.site/news/TOP%20STORY/2549086/... </font>
DEPO, which has thus far hit a 52-week low of $1.01 and 52-week high of $4.25, closed Friday's trading at $4.16.
With three pending late-stage trial results, the upcoming events are make-or-break events for DepoMed as the stock is poised to surge overnight on success or crater on failure to achieve its primary endpoints. Assuming positive trial data, the company expects to file New Drug Application for both the drugs in the first quarter of 2010.
$4.16 (09/27/09)
